Concepts (736)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 234 | 2023 | 2645 | 18.340 |
Why?
|
| Cerebral Amyloid Angiopathy | 77 | 2023 | 879 | 5.670 |
Why?
|
| Hematoma | 40 | 2023 | 768 | 4.690 |
Why?
|
| Stroke | 118 | 2024 | 9879 | 4.300 |
Why?
|
| Brain Ischemia | 56 | 2022 | 3127 | 3.140 |
Why?
|
| Cerebral Angiography | 25 | 2021 | 1252 | 2.080 |
Why?
|
| Leukoaraiosis | 13 | 2022 | 116 | 2.060 |
Why?
|
| Warfarin | 25 | 2017 | 1506 | 1.950 |
Why?
|
| Anticoagulants | 34 | 2023 | 4830 | 1.690 |
Why?
|
| Genetic Predisposition to Disease | 60 | 2022 | 17648 | 1.610 |
Why?
|
| Genome-Wide Association Study | 71 | 2023 | 12447 | 1.530 |
Why?
|
| Intracranial Hemorrhages | 14 | 2023 | 843 | 1.470 |
Why?
|
| Caregivers | 17 | 2022 | 2172 | 1.370 |
Why?
|
| Polymorphism, Single Nucleotide | 66 | 2023 | 15645 | 1.370 |
Why?
|
| Siderosis | 9 | 2023 | 103 | 1.230 |
Why?
|
| Brain | 58 | 2024 | 26655 | 1.200 |
Why?
|
| Aged | 267 | 2024 | 166562 | 1.200 |
Why?
|
| Apolipoprotein E4 | 12 | 2020 | 688 | 1.150 |
Why?
|
| Resilience, Psychological | 10 | 2020 | 702 | 1.140 |
Why?
|
| Genetic Variation | 29 | 2024 | 6507 | 1.130 |
Why?
|
| Hypertension | 29 | 2023 | 8496 | 1.100 |
Why?
|
| Aged, 80 and over | 146 | 2024 | 58300 | 1.050 |
Why?
|
| Apolipoproteins E | 20 | 2019 | 1431 | 1.020 |
Why?
|
| Humans | 454 | 2024 | 752341 | 1.010 |
Why?
|
| Middle Aged | 243 | 2024 | 217019 | 0.990 |
Why?
|
| Tomography, X-Ray Computed | 56 | 2023 | 20348 | 0.960 |
Why?
|
| Hematoma, Subdural | 2 | 2024 | 126 | 0.950 |
Why?
|
| Male | 302 | 2024 | 354881 | 0.940 |
Why?
|
| Intensive Care Units | 19 | 2022 | 3697 | 0.910 |
Why?
|
| Female | 299 | 2024 | 386053 | 0.880 |
Why?
|
| Leukoencephalopathies | 8 | 2022 | 248 | 0.860 |
Why?
|
| Recovery of Function | 16 | 2024 | 2921 | 0.850 |
Why?
|
| Cerebrovascular Disorders | 11 | 2020 | 1492 | 0.840 |
Why?
|
| Apolipoprotein E2 | 10 | 2019 | 131 | 0.830 |
Why?
|
| Magnetic Resonance Imaging | 103 | 2024 | 35916 | 0.830 |
Why?
|
| Family | 7 | 2021 | 3165 | 0.820 |
Why?
|
| Brain Edema | 7 | 2020 | 595 | 0.750 |
Why?
|
| Collagen Type IV | 5 | 2017 | 128 | 0.740 |
Why?
|
| Cerebral Arteries | 8 | 2017 | 491 | 0.740 |
Why?
|
| Brain Injuries | 6 | 2021 | 1967 | 0.720 |
Why?
|
| Cerebellar Diseases | 3 | 2021 | 219 | 0.720 |
Why?
|
| Depression | 21 | 2022 | 7917 | 0.710 |
Why?
|
| Boxing | 1 | 2019 | 17 | 0.700 |
Why?
|
| Atrial Fibrillation | 20 | 2023 | 5146 | 0.700 |
Why?
|
| Arteriolosclerosis | 1 | 2019 | 21 | 0.690 |
Why?
|
| Blood Pressure | 18 | 2022 | 8467 | 0.690 |
Why?
|
| Genotype | 46 | 2022 | 12869 | 0.680 |
Why?
|
| Critical Illness | 9 | 2021 | 2685 | 0.680 |
Why?
|
| Head | 2 | 2022 | 911 | 0.670 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 9 | 2022 | 3308 | 0.660 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 3 | 2011 | 101 | 0.650 |
Why?
|
| Prospective Studies | 86 | 2024 | 53807 | 0.650 |
Why?
|
| Brain Diseases | 5 | 2019 | 1544 | 0.640 |
Why?
|
| Risk Factors | 107 | 2024 | 73412 | 0.640 |
Why?
|
| Cohort Studies | 80 | 2024 | 40984 | 0.640 |
Why?
|
| Hospitals, Rural | 1 | 2020 | 174 | 0.630 |
Why?
|
| Drainage | 1 | 2024 | 1153 | 0.630 |
Why?
|
| Hospitals, Urban | 1 | 2020 | 494 | 0.620 |
Why?
|
| Survivors | 10 | 2022 | 2324 | 0.610 |
Why?
|
| Genetic Association Studies | 13 | 2019 | 2711 | 0.610 |
Why?
|
| Cerebral Cortex | 15 | 2019 | 5697 | 0.600 |
Why?
|
| Platelet Aggregation Inhibitors | 9 | 2019 | 3160 | 0.590 |
Why?
|
| Hemosiderosis | 4 | 2020 | 66 | 0.590 |
Why?
|
| Gene Frequency | 13 | 2019 | 3586 | 0.580 |
Why?
|
| Critical Care | 10 | 2019 | 2676 | 0.560 |
Why?
|
| Severity of Illness Index | 28 | 2021 | 15676 | 0.550 |
Why?
|
| Stress Disorders, Post-Traumatic | 10 | 2023 | 4470 | 0.550 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 2 | 2006 | 49 | 0.540 |
Why?
|
| Adaptation, Psychological | 11 | 2022 | 2591 | 0.510 |
Why?
|
| Genetic Loci | 12 | 2021 | 2602 | 0.510 |
Why?
|
| Alleles | 13 | 2018 | 6879 | 0.510 |
Why?
|
| Hospital Mortality | 12 | 2020 | 5369 | 0.510 |
Why?
|
| Antihypertensive Agents | 7 | 2021 | 2037 | 0.510 |
Why?
|
| Anticonvulsants | 3 | 2015 | 1881 | 0.490 |
Why?
|
| Subarachnoid Hemorrhage | 7 | 2021 | 1025 | 0.490 |
Why?
|
| Brain Stem Hemorrhage, Traumatic | 1 | 2014 | 13 | 0.490 |
Why?
|
| Urinary Tract Infections | 3 | 2018 | 810 | 0.480 |
Why?
|
| Lymphopenia | 1 | 2017 | 289 | 0.480 |
Why?
|
| Propylene Glycols | 1 | 2014 | 89 | 0.470 |
Why?
|
| Recurrence | 21 | 2021 | 8420 | 0.470 |
Why?
|
| Cerebral Ventricles | 2 | 2019 | 540 | 0.470 |
Why?
|
| Professional-Family Relations | 3 | 2021 | 488 | 0.470 |
Why?
|
| Longitudinal Studies | 33 | 2024 | 14325 | 0.470 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 3 | 2010 | 253 | 0.460 |
Why?
|
| Amyloid | 5 | 2022 | 825 | 0.450 |
Why?
|
| Disease Progression | 28 | 2023 | 13402 | 0.450 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2013 | 93 | 0.450 |
Why?
|
| Myocardial Infarction | 9 | 2023 | 11830 | 0.450 |
Why?
|
| Nerve Fibers, Myelinated | 6 | 2013 | 953 | 0.440 |
Why?
|
| Microvessels | 3 | 2017 | 570 | 0.440 |
Why?
|
| Research | 1 | 2022 | 1962 | 0.440 |
Why?
|
| Retrospective Studies | 71 | 2023 | 79127 | 0.440 |
Why?
|
| Mendelian Randomization Analysis | 7 | 2023 | 972 | 0.430 |
Why?
|
| Glasgow Coma Scale | 13 | 2021 | 562 | 0.430 |
Why?
|
| Imines | 1 | 2012 | 33 | 0.430 |
Why?
|
| Cerebral Infarction | 7 | 2018 | 980 | 0.420 |
Why?
|
| Multivariate Analysis | 24 | 2020 | 12137 | 0.420 |
Why?
|
| Case-Control Studies | 37 | 2022 | 21841 | 0.410 |
Why?
|
| Sphingosine | 1 | 2014 | 308 | 0.410 |
Why?
|
| Leukocyte Count | 1 | 2016 | 1590 | 0.400 |
Why?
|
| Brain Infarction | 5 | 2021 | 290 | 0.400 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 2 | 2023 | 53 | 0.400 |
Why?
|
| Receptor, PAR-1 | 1 | 2012 | 113 | 0.400 |
Why?
|
| Predictive Value of Tests | 31 | 2021 | 15130 | 0.400 |
Why?
|
| Receptors, Complement 3b | 1 | 2012 | 135 | 0.390 |
Why?
|
| Image Processing, Computer-Assisted | 23 | 2021 | 8931 | 0.390 |
Why?
|
| Anxiety | 8 | 2022 | 4456 | 0.390 |
Why?
|
| Decision Making | 4 | 2022 | 3890 | 0.390 |
Why?
|
| Catechol O-Methyltransferase | 4 | 2024 | 247 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2010 | 534 | 0.380 |
Why?
|
| Nervous System Diseases | 5 | 2018 | 1624 | 0.380 |
Why?
|
| Epilepsy | 4 | 2023 | 3313 | 0.380 |
Why?
|
| CADASIL | 4 | 2016 | 88 | 0.370 |
Why?
|
| Risk | 18 | 2019 | 9613 | 0.370 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2017 | 1101 | 0.370 |
Why?
|
| Postoperative Hemorrhage | 1 | 2014 | 408 | 0.370 |
Why?
|
| Prognosis | 39 | 2023 | 29327 | 0.360 |
Why?
|
| Plasma | 6 | 2017 | 582 | 0.350 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 642 | 0.350 |
Why?
|
| Lactones | 1 | 2012 | 320 | 0.350 |
Why?
|
| Length of Stay | 7 | 2014 | 6372 | 0.350 |
Why?
|
| Hematoma, Subdural, Intracranial | 3 | 2017 | 30 | 0.350 |
Why?
|
| Adult | 84 | 2024 | 216913 | 0.340 |
Why?
|
| Principal Component Analysis | 4 | 2014 | 935 | 0.340 |
Why?
|
| Cognition Disorders | 15 | 2017 | 3970 | 0.340 |
Why?
|
| Cerebral Arterial Diseases | 3 | 2019 | 82 | 0.340 |
Why?
|
| Personal Satisfaction | 1 | 2014 | 640 | 0.340 |
Why?
|
| Pneumonia | 3 | 2018 | 2121 | 0.330 |
Why?
|
| Mutation | 7 | 2023 | 29705 | 0.310 |
Why?
|
| Migraine without Aura | 2 | 2022 | 82 | 0.310 |
Why?
|
| Alzheimer Disease | 16 | 2023 | 8432 | 0.310 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 12 | 2022 | 2767 | 0.310 |
Why?
|
| Glutamic Acid | 1 | 2013 | 1160 | 0.310 |
Why?
|
| Genetic Testing | 4 | 2019 | 3505 | 0.300 |
Why?
|
| Atrophy | 4 | 2020 | 1606 | 0.300 |
Why?
|
| Factor VIIa | 3 | 2007 | 98 | 0.300 |
Why?
|
| Blood Coagulation | 5 | 2019 | 1149 | 0.300 |
Why?
|
| Vitamin K | 6 | 2017 | 319 | 0.300 |
Why?
|
| Genetics, Population | 2 | 2010 | 921 | 0.300 |
Why?
|
| Brain Concussion | 5 | 2023 | 1355 | 0.290 |
Why?
|
| Erythrocyte Transfusion | 2 | 2013 | 555 | 0.290 |
Why?
|
| Logistic Models | 22 | 2021 | 13277 | 0.280 |
Why?
|
| Migraine with Aura | 2 | 2022 | 203 | 0.280 |
Why?
|
| International Normalized Ratio | 6 | 2017 | 379 | 0.280 |
Why?
|
| Comorbidity | 12 | 2020 | 10475 | 0.270 |
Why?
|
| Thromboembolism | 3 | 2019 | 997 | 0.270 |
Why?
|
| Sepsis | 2 | 2018 | 2588 | 0.270 |
Why?
|
| Statistics, Nonparametric | 9 | 2017 | 2842 | 0.270 |
Why?
|
| Risk Assessment | 24 | 2023 | 23783 | 0.270 |
Why?
|
| Aspirin | 5 | 2014 | 3341 | 0.270 |
Why?
|
| Sex Factors | 12 | 2021 | 10455 | 0.270 |
Why?
|
| Odds Ratio | 19 | 2021 | 9701 | 0.270 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2017 | 1422 | 0.260 |
Why?
|
| Models, Cardiovascular | 1 | 2011 | 970 | 0.260 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 2 | 2017 | 19 | 0.260 |
Why?
|